Latest drug prices and trends for NDC 00904-1987

Subscribe to access the full database, or Try for Free
Drug Name	NDC	Price/Unit ($)	Unit	Date
MAPAP 500 MG CAPSULE	00904-1987-60	0.03604	EACH	2025-03-19
MAPAP 500 MG CAPSULE	00904-1987-60	0.03618	EACH	2025-02-19
MAPAP 500 MG CAPSULE	00904-1987-60	0.03611	EACH	2025-01-22
MAPAP 500 MG CAPSULE	00904-1987-60	0.03584	EACH	2024-12-18
MAPAP 500 MG CAPSULE	00904-1987-60	0.03616	EACH	2024-11-20
MAPAP 500 MG CAPSULE	00904-1987-60	0.03542	EACH	2024-10-23
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Subscribe to access the full database, or Try for Free

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Dates	>Price Type

Introduction

In the ever-evolving pharmaceutical landscape, understanding market trends and price projections for specific drugs is crucial for healthcare providers, payers, and patients alike. This article delves into the market analysis and price projections for NDC 00904-1987, also known as MAPAP Extra Strength, manufactured by Major Pharmaceuticals. As we navigate through the complexities of drug pricing and market dynamics, we'll explore various factors influencing the future of this particular medication.

Understanding NDC 00904-1987: MAPAP Extra Strength

MAPAP Extra Strength is a brand name for acetaminophen, a widely used over-the-counter pain reliever and fever reducer. Acetaminophen is known for its effectiveness in treating mild to moderate pain and reducing fever, making it a staple in many households and healthcare settings.

Key Features of MAPAP Extra Strength

Active Ingredient: Acetaminophen
Strength: Extra Strength formulation
Manufacturer: Major Pharmaceuticals
NDC Code: 00904-1987

Current Market Position

As of 2025, MAPAP Extra Strength holds a significant position in the over-the-counter pain relief market. Its accessibility and well-established safety profile contribute to its popularity among consumers and healthcare professionals.

Market Share and Competitors

While specific market share data for MAPAP Extra Strength is not provided in the search results, it's important to note that acetaminophen products face competition from other over-the-counter pain relievers such as ibuprofen and aspirin. The market for these products is generally mature and competitive.

Historical Price Trends

To understand future price projections, it's crucial to examine historical price trends for acetaminophen products and the pharmaceutical market as a whole.

Generic Drug Price Trends

In the generic drug market, prices are generally expected to erode annually by mid-single-digit percentages. This trend is consistent with the current outlook for generic drugs[4].

This general trend in generic drug pricing provides context for potential price movements of MAPAP Extra Strength, as it competes in a market with both branded and generic alternatives.

Brand Name Drug Price Trends

While MAPAP Extra Strength is not a brand-name prescription drug, it's worth noting the broader trends in pharmaceutical pricing:

From January 2022 to January 2023, the average price increase for brand-name drugs was 7.4% ($958)[2].
Multi-source drugs (those with generic alternatives) saw an average increase of 26.0% ($69) during the same period[2].

These trends in the broader pharmaceutical market may indirectly influence pricing strategies for over-the-counter medications like MAPAP Extra Strength.

Factors Influencing Future Pricing

Several factors are likely to impact the pricing of MAPAP Extra Strength in the coming years:

1. Raw Material Costs

The cost of acetaminophen as a raw material can fluctuate based on global supply and demand, potentially affecting the final product price.

2. Manufacturing Efficiency

Improvements in manufacturing processes or economies of scale could lead to cost reductions, potentially influencing pricing strategies.

3. Market Competition

The presence of numerous acetaminophen products in the market creates competitive pressure on pricing.

4. Regulatory Environment

Changes in regulations regarding over-the-counter medications could impact pricing strategies and market dynamics.

5. Consumer Demand

Shifts in consumer preferences or healthcare trends may influence demand and, consequently, pricing.

Price Projections for 2025 and Beyond

While specific price projections for MAPAP Extra Strength are not available in the search results, we can make some informed estimates based on general market trends and historical data.

Short-term Projections (2025-2026)

Given the competitive nature of the over-the-counter pain relief market and the general trend of price erosion in generic drugs, it's reasonable to expect relatively stable pricing for MAPAP Extra Strength in the short term. Any price increases are likely to be modest, potentially in line with inflation or slightly below.

Medium-term Projections (2026-2028)

In the medium term, pricing may be more influenced by broader market dynamics and potential shifts in manufacturing costs or regulatory requirements. While significant price hikes are unlikely due to market competition, small incremental increases may occur to offset rising costs or maintain profit margins.

Long-term Projections (2028 and beyond)

Long-term price projections are more speculative and will depend on various factors, including:

Potential innovations in pain relief medications
Changes in healthcare policies and regulations
Shifts in consumer behavior and healthcare trends

It's possible that pricing strategies may need to adapt to changing market conditions, potentially leading to more dynamic pricing models or value-based pricing approaches.

Impact of Industry Trends on MAPAP Extra Strength

Several broader industry trends are likely to influence the market position and pricing of MAPAP Extra Strength in the coming years:

1. Shift Towards Value-Based Healthcare

The ongoing transition to value-based healthcare models may impact how over-the-counter medications are perceived and priced. Products that can demonstrate superior efficacy or cost-effectiveness may have an advantage in this evolving landscape.

2. Increased Focus on Personalized Medicine

While personalized medicine primarily affects prescription drugs, the trend towards tailored healthcare solutions may influence consumer expectations for over-the-counter products as well. This could potentially lead to the development of more targeted formulations or dosage options.

3. Digital Health Integration

The integration of digital health technologies may create opportunities for enhanced patient education and engagement around over-the-counter pain relief options. This could potentially influence brand loyalty and pricing strategies.

4. Sustainability and Environmental Concerns

Growing consumer awareness of environmental issues may lead to increased demand for sustainably produced and packaged medications. This could impact manufacturing costs and, consequently, pricing strategies.

Potential Market Disruptions

Several factors could potentially disrupt the market for acetaminophen products like MAPAP Extra Strength:

1. Novel Pain Relief Technologies

The development of new, non-pharmacological pain relief technologies could potentially impact the demand for traditional over-the-counter pain medications.

2. Regulatory Changes

Changes in regulations governing the sale or marketing of over-the-counter pain relievers could significantly impact the market landscape.

3. Shifts in Consumer Preferences

Growing interest in natural or alternative pain relief methods could potentially affect demand for acetaminophen products.

4. Supply Chain Disruptions

Global events or geopolitical tensions could potentially disrupt supply chains, affecting the availability and pricing of raw materials or finished products.

Strategies for Stakeholders

Given the market analysis and price projections for MAPAP Extra Strength, various stakeholders may consider the following strategies:

For Healthcare Providers

Stay informed about pricing trends and alternatives to ensure cost-effective recommendations for patients.
Consider patient education initiatives on the appropriate use of over-the-counter pain relievers.

For Payers

Monitor pricing trends in the over-the-counter market to inform formulary decisions for prescription alternatives.
Consider value-based arrangements that may include over-the-counter options as part of comprehensive pain management strategies.

For Consumers

Compare prices across different brands and retailers to ensure cost-effective purchases.
Stay informed about proper usage and potential risks associated with acetaminophen products.

For Manufacturers

Invest in manufacturing efficiencies to maintain competitive pricing.
Explore value-added services or formulations to differentiate products in a crowded market.
Monitor regulatory developments and adapt strategies accordingly.

Future Outlook

The future of MAPAP Extra Strength and similar acetaminophen products is likely to be shaped by a combination of market forces, technological advancements, and evolving healthcare paradigms. While the core demand for effective pain relief is likely to remain strong, the specific ways in which this demand is met may evolve.

Manufacturers of over-the-counter pain relievers will need to remain agile, adapting to changing consumer preferences and regulatory landscapes. Innovation in formulation, packaging, or accompanying digital tools may become increasingly important differentiators in a competitive market.

Key Takeaways

MAPAP Extra Strength (NDC 00904-1987) is a widely used acetaminophen product in a competitive over-the-counter pain relief market.
Historical trends suggest relatively stable pricing for generic drugs, with potential for modest increases in line with broader market dynamics.
Future pricing will be influenced by factors including raw material costs, manufacturing efficiency, market competition, and regulatory changes.
Short-term price projections indicate relative stability, while medium to long-term projections are more uncertain and dependent on various market factors.
Industry trends such as value-based healthcare, personalized medicine, and digital health integration may impact the market position of over-the-counter pain relievers.
Stakeholders should stay informed about market trends and be prepared to adapt strategies in response to potential disruptions or shifts in consumer preferences.

FAQs

Q: How often do prices typically change for over-the-counter medications like MAPAP Extra Strength? A: Price changes for over-the-counter medications can vary, but they often align with annual cycles or significant market events. However, specific timing can differ based on manufacturer strategies and market conditions.
Q: Are there any upcoming regulatory changes that could affect the pricing of acetaminophen products? A: As of 2025, there are no specific regulatory changes announced that would directly impact acetaminophen pricing. However, ongoing discussions about drug pricing transparency and healthcare reform could potentially influence the market in the future.
Q: How does the pricing of MAPAP Extra Strength compare to prescription pain relievers? A: Generally, over-the-counter medications like MAPAP Extra Strength are significantly less expensive than prescription pain relievers. However, exact price comparisons would depend on specific products, dosages, and market conditions.
Q: Can technological advancements impact the production costs and pricing of acetaminophen products? A: Yes, advancements in manufacturing technology or process improvements could potentially reduce production costs, which might influence pricing strategies. However, the impact on consumer prices would also depend on market competition and other factors.
Q: How might future developments in pain management affect the market for products like MAPAP Extra Strength? A: Emerging pain management techniques or alternative therapies could potentially impact the market for traditional over-the-counter pain relievers. However, given the established efficacy and safety profile of acetaminophen, it's likely to remain a significant player in pain management for the foreseeable future.

Sources cited: [2] https://aspe.hhs.gov/sites/default/files/documents/0cdd88059165eef3bed1fc587a0fd68a/aspe-drug-price-tracking-brief.pdf [4] https://www.drugpatentwatch.com/p/drug-price/ndc/00093-8739 [9] https://www.findacode.com/ndc/labelers/Major_Pharmaceuticals